OrthoPediatrics/$KIDS
About OrthoPediatrics
Ticker
Industry
Employees
OrthoPediatrics Metrics
$570M
-
-$1.24
1.16
-
Price and volume
Market cap
$570M
Beta
1.16
52-week high
$35.99
52-week low
$21.02
Average daily volume
275K
Financial strength
Current ratio
7.171
Quick ratio
3.434
Long term debt to equity
20.844
Total debt to equity
21.364
Interest coverage (TTM)
-24.24%
Management effectiveness
Return on assets (TTM)
-3.94%
Return on equity (TTM)
-7.63%
Valuation
Price to revenue (TTM)
2.853
Price to book
1.54
Price to tangible book (TTM)
2.92
Price to free cash flow (TTM)
-10.595
Growth
Revenue change (TTM)
33.47%
Earnings per share change (TTM)
23.84%
3-year revenue growth (CAGR)
27.20%
3-year earnings per share growth (CAGR)
-7.82%
What the Analysts think about OrthoPediatrics
Analyst Ratings
OrthoPediatrics Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
OrthoPediatrics Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
OrthoPediatrics News
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
FAQs
What’s the current market cap for OrthoPediatrics stock?
What is the P/E ratio for OrthoPediatrics stock?
Does OrthoPediatrics stock pay dividends?
No, OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next OrthoPediatrics dividend payment date?
OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders.
What is the beta indicator for OrthoPediatrics?
OrthoPediatrics (KIDS) has a beta rating of 1.16. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.